STE-101

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameSTE-101
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitochondrial complex I (NADH dehydrogenase) inhibitorsElectron transport complex III inhibitors
TargetsMitochondrial complex I (NADH dehydrogenase)Electron transport complex III
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStemergie Biotechnology SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStemergie Biotechnology SA
Active IndicationsN/A
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksN/A